These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6327601)

  • 21. [Cefmenoxime penetration into the vitreous body of the human eye after subconjunctival injection].
    Duncker G; Eckardt C; Ullmann U
    Fortschr Ophthalmol; 1988; 85(2):210-2. PubMed ID: 3164698
    [No Abstract]   [Full Text] [Related]  

  • 22. Intraocular penetration of cefmenoxime (SCE-1365), A new cephalosporin, in humans.
    Takahashi N; Takahashi K; Takagi M
    Nippon Ganka Gakkai Zasshi; 1982; 86(4):337-40. PubMed ID: 6287821
    [No Abstract]   [Full Text] [Related]  

  • 23. [HPLC study of the inhibition of enterobacterial cephalosporinases by cefmenoxime].
    Pechinot A; Duez JM; Bryskier A; Labia R; Kazmierczak A
    Pathol Biol (Paris); 1984 May; 32(5):386-8. PubMed ID: 6330649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Experimental study on transferability to cerebrospinal fluid of cefodizime in combination with ampicillin].
    Okura K; Haruta T; Kobayashi Y
    Jpn J Antibiot; 1989 Jun; 42(6):1286-92. PubMed ID: 2795853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical trial of cefmenoxime in children].
    Okada T; Furukawa S
    Jpn J Antibiot; 1982 Nov; 35(11):2589-98. PubMed ID: 6302340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Bacteriologic, clinical and kinetic evaluation of cefmenoxime (SCE 1365) in the treatment of 68 cases of septicemia. A multicenter trial].
    Bryskier A; Sollet JP; Bleichner G; Segrestaa JM; Guerin JM; Dureux JB; Canton P; Veyssier P; Lallement PY; Mottin J
    Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):547-51. PubMed ID: 6087250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Penetration of cefmenoxime into serum, gynecologic tissues, and heart valves.
    Daschner FD; Petersen EE; Frank U; Hornig D
    Am J Med; 1984 Dec; 77(6A):4-6. PubMed ID: 6097123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diffusion of ceftriaxone into the cerebrospinal fluid of adults.
    Chandrasekar PH; Rolston KV; Smith BR; LeFrock JL
    J Antimicrob Chemother; 1984 Oct; 14(4):427-30. PubMed ID: 6094424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [In vitro activity of cefmenoxime (SCE 1365) against 616 hospital strains of gram-negative bacilli chosen for beta-lactam resistance. Comparison with cefotaxime, lamoxactam and ceftazidime].
    Le Noc P; Bryskier A; Le Noc D
    Pathol Biol (Paris); 1983 May; 31(5):351-6. PubMed ID: 6312396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A study on the penetration of cefmenoxime into bile and gallbladder tissues and the pathological changes of inflamed tissues].
    Tsuburaya H; Ando Y; Kimizima I; Watanabe I; Abe R; Funayama T; Kawaguchi Y
    Jpn J Antibiot; 1986 Sep; 39(9):2381-5. PubMed ID: 3467080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cefmenoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Campoli-Richards DM; Todd PA
    Drugs; 1987 Aug; 34(2):188-221. PubMed ID: 3304966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical studies on cefmenoxime in pediatric field].
    Yanagisawa K; Yanagisawa K; Hoshina H; Ichihashi H
    Jpn J Antibiot; 1982 Oct; 35(10):2414-22. PubMed ID: 6306293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cefotaxime monotherapy in bacterial meningitis in childhood].
    Helwig H; Schlegel P
    Monatsschr Kinderheilkd; 1986 Oct; 134(10):733-7. PubMed ID: 3796634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Penetration of cefmenoxime into pleural fluid].
    Miyazaki N; Kajiki A; Yamazaki H; Harada S; Kido M; Kuroiwa A
    Jpn J Antibiot; 1984 Oct; 37(10):1763-5. PubMed ID: 6094856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [In vitro study of the synergistic effect of cefmenoxime-aminoglycoside combinations apropos of 148 strains of Enterobacteriaceae].
    Husson MO; Izard D; Bryskier A; Leclerc H
    Pathol Biol (Paris); 1984 May; 32(5):396-8. PubMed ID: 6330651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination effect of cefmenoxime with four aminoglycosides on Enterobacteriaceae susceptible and moderately susceptible to this new cephalosporin.
    Husson MO; Izard D; Bryskier A; Vincent P; Leclerc H
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Aug; 257(3):383-7. PubMed ID: 6091368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disulfiram-like reaction to cefmenoxime.
    Smith BR; LeFrock JL
    N Y State J Med; 1984 Jan; 84(1):7-8. PubMed ID: 6322073
    [No Abstract]   [Full Text] [Related]  

  • 38. In vitro activity of cefmenoxime, cefotaxime, latamoxef, cefazolin, nafcillin and vancomycin against 53 endocarditis and bacteremic strains of Staphylococcus aureus.
    Dhawan VK; Maier MK; Nayyar M; Chuah SK; Thadepalli H
    Chemotherapy; 1984; 30(5):328-30. PubMed ID: 6092007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [In-vitro activity of ceftriaxone on Gram-negative bacilli with various resistance phenotypes to cephalosporins. Comparison with cefotaxime, cefmenoxime, moxalactam, ceftazidime].
    Rouhan D; Le Noc P; Le Noc D
    Pathol Biol (Paris); 1986 May; 34(5):404-9. PubMed ID: 3534713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cefmenoxime: a new broad-spectrum antibiotic. 13th International Congress on Chemotherapy. Vienna, Austria, August 28 to September 2, 1983.
    Am J Med; 1984 Dec; 77(6A):1-59. PubMed ID: 6097115
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.